• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve)
ConclusionsAmong patients with diabetes and severe symptomatic AS at high risk for surgery, this post-hoc stratified analysis of the PARTNER trial suggests there is a survival benefit, no increase in stroke, and less renal failure from treatment with transcatheter AVR compared with surgical AVR. (The PARTNER Trial: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - March 17, 2014 Category: Cardiology Source Type: research

Impact of right and left ventricular systolic dysfunction on perioperative outcome and long ‐term survival after transcatheter aortic valve replacement
ConclusionsPeri‐operative mortality and risk of stroke after TAVR are not adversely affected by preexisting RV or LV dysfunction. Long‐term survival is impaired in patients with RVSD. RVSD but not LVSD is an independent risk factor for late mortality. TAVR should be the preferred therapy for patients with RVSD and LVSD, especially when patient is suitable for TF.
Source: Journal of Interventional Cardiology - April 25, 2017 Category: Cardiology Authors: Daniel P. Griese, Sebastian Kerber, Sebastian Barth, Anno Diegeler, J örg Babin‐Ebell, Wilko Reents Tags: ORIGINAL INVESTIGATION Source Type: research

Midterm Outcomes of Transcatheter Aortic Valve Replacement in Dialysis Patients With Aortic Valve Stenosis.
CONCLUSIONS: Satisfactory in-hospital outcomes were achieved in dialysis patients after TAVR. Various problems, however, such as complications particular to dialysis patients and valve durability, remained at midterm follow-up. Further studies are recommended to solve these problems, and prudent preoperative assessments should be mandatory. PMID: 31118365 [PubMed - as supplied by publisher]
Source: Circulation Journal - May 22, 2019 Category: Cardiology Authors: Maeda K, Kuratani T, Mizote I, Shimamura K, Ichibori Y, Onishi T, Nakatani S, Ueno T, Toda K, Sakata Y, Sawa Y Tags: Circ J Source Type: research

P113 * Clinical outcomes following double and triple valve surgery in Hong Kong
Conclusion: Patient requiring double and triple valve surgeries represent a heterogeneous and complex group of patients. They are a significant portion of patients undergoing valve surgery in our Institution. Outcomes in comparison to pre-operative risk scores and International Databases are satisfactory.
Source: European Journal of Heart Failure Supplements - February 23, 2012 Category: Cardiology Authors: Wong, H. L., Ng, S. H., Kwok, W. T., Yeung, C. L., Yu, S. Y., Wan, Y. P., Wan, S., Underwood, M. J., Bai, W. J., Li, H., Tang, H., Wang, H., Rao, L., Li, H., Bai, W. J., Chen, Y., Tang, H., Peng, Y., Rao, L., Park, Y. H., Han, D. C., Sohn, C. B., Kim, J. Tags: Valvular Heart Disease Source Type: research

Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis Valvular Heart Disease
Conclusions Six-month mortality after IE is 25% and is predicted by host factors, IE characteristics, and IE complications. Surgery during the index hospitalization is associated with lower mortality but is performed less frequently in the highest risk patients. A simplified risk model may be used to identify specific risk subgroups in IE.
Source: JAHA:Journal of the American Heart Association - April 17, 2016 Category: Cardiology Authors: Park, L. P., Chu, V. H., Peterson, G., Skoutelis, A., Lejko-Zupa, T., Bouza, E., Tattevin, P., Habib, G., Tan, R., Gonzalez, J., Altclas, J., Edathodu, J., Fortes, C. Q., Siciliano, R. F., Pachirat, O., Kanj, S., Wang, A., for the International Collaborat Tags: Clinical Studies, Infectious Endocarditis, Valvular Heart Disease, Mortality/Survival Source Type: research

How Good is EPS at Predicting the Future After TAVR?
Permanent pacemaker (PPM) implantation continues to be a significant complication of transcatheter aortic valve replacement (TAVR), occurring in approximately 12% of patients [1]. While device enhancements of new TAVR valves, better patient selection and operator experience have led to a decrease in paravalvular regurgitation, vascular injury, stroke, and new dialysis requirement, pacemaker implantation appears to be the only complication that is increasing in frequency [1]. As TAVR expands to patients with lower risk, the long-term consequences of pacemaker implantation will likely be amplified.
Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Brett A. Oestreich, Santiago Garcia Source Type: research

Abstract 016: Endovascular Management of Major Vascular Access Site Complications During Transcatheter Aortic Valve Implantation (TAVI). Session Title: Poster Session I
Conclusion: Many patients with major vascular complications during TAVI can be treated with a pure endovascular approach. In our small series we observed no difference in concurrent complications when an endovascular repair can be rapidly initiated as compared to a primary surgical approach.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Majeed, M. U., Green, K. D., Fudim, M., Robbins, M. A., Zhao, D. X. Tags: Session Title: Poster Session I Source Type: research

Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement
Conclusions Patients with CKD or ESRD have worse in-hospital outcomes after TAVR. AKI is associated with higher in-hospital mortality in patients undergoing TAVR and the incidence of AKI has not declined over the years.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - October 16, 2017 Category: Cardiology Authors: Gupta, T., Goel, K., Kolte, D., Khera, S., Villablanca, P. A., Aronow, W. S., Bortnick, A. E., Slovut, D. P., Taub, C. C., Kizer, J. R., Pyo, R. T., Abbott, J. D., Fonarow, G. C., Rihal, C. S., Garcia, M. J., Bhatt, D. L. Tags: Structural Source Type: research

Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Chronic Kidney Disease
There are few data comparing outcomes of transcatheter aortic valve implantation (TAVI) vs. surgical aortic valve replacement (SAVR) in patients with chronic kidney disease (CKD). In this retrospective cohort study using the National Inpatient Sample 2011 – 2014, we included a total of 2820 TAVI and 4054 SAVR procedures, representative of 14,039 TAVI and 19,835 SAVR procedures nationally. Co-primary outcomes were in-hospital mortality, acute kidney injury (AKI), dialysis-requiring AKI, and post-operative stroke.
Source: The American Journal of Cardiology - October 31, 2017 Category: Cardiology Authors: Nilay Kumar, Rohan Khera, Neetika Garg, Justin B. Echouffo-Tcheugui, Anand Venkatraman, Ambarish Pandey, Deepak L. Bhatt Source Type: research

Transcatheter or surgical aortic valve replacement in patients with advanced kidney disease: A propensity score –matched analysis
ConclusionsIn patients with advanced kidney disease, SAVR was associated with higher mortality and higher periprocedural complications, as compared with TAVR. Thus, benefits of TAVR could be extended in patients with advanced kidney disease who cannot undergo surgery.
Source: Clinical Cardiology - October 1, 2017 Category: Cardiology Authors: Rajkumar Doshi, Jay Shah, Vaibhav Patel, Varun Jauhar, Perwaiz Meraj Tags: CLINICAL INVESTIGATIONS Source Type: research

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes Structural Heart Disease
Conclusions— TAVR is being increasingly used as the preferred modality of AVR in patients with prior CABG. Compared with SAVR, TAVR is associated with similar in-hospital mortality but lower rates of in-hospital complications in this important subset of patients.
Source: Circulation: Cardiovascular Interventions - April 11, 2018 Category: Cardiology Authors: Gupta, T., Khera, S., Kolte, D., Goel, K., Kalra, A., Villablanca, P. A., Aronow, H. D., Abbott, J. D., Fonarow, G. C., Taub, C. C., Kleiman, N. S., Weisz, G., Inglessis, I., Elmariah, S., Rihal, C. S., Garcia, M. J., Bhatt, D. L. Tags: Aortic Valve Replacement/Transcatheter Aortic Valve Implantation Structural Heart Disease Source Type: research

Impact of Discharge Location After Transcatheter Aortic Valve Replacement On 1-Year Outcomes In Women: Results From The WIN-TAVI Registry
ConclusionsIn women undergoing contemporary TAVR, discharge disposition significantly affects 1-year risk of outcomes even after adjustment for recorded baseline differences. This might suggest the necessity of considering additional factors beyond comorbidities in the TAVR decision-making process.
Source: Canadian Journal of Cardiology - December 12, 2018 Category: Cardiology Source Type: research

Predictors of Cumulative Health Care Costs Associated with Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis
ConclusionsThis analysis shows that there are 3 distinct phases of cost accumulation from referral to post-TAVR with some potentially modifiable cost drivers in each phase.
Source: Canadian Journal of Cardiology - December 18, 2019 Category: Cardiology Source Type: research

Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy
ConclusionsSeptal myectomy, performed in a tertiary referral center, had a 30-day mortality rate of 0% and low morbidity rate. There was no difference between observed myectomy mortality and STS Calculator predicted risk for AVR and MV repair. It is possible that a larger sample could reveal lower mortality than STS prediction.
Source: American Heart Journal - December 19, 2019 Category: Cardiology Source Type: research

Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis
CONCLUSIONS: PVE carried significant perioperative risks, and was an independent risk factor of overall mortality.PMID:34085423 | DOI:10.4070/kcj.2020.0448
Source: Korean Circulation Journal - June 4, 2021 Category: Cardiology Authors: Won Kyung Pyo Ho Jin Kim Joon Bum Kim Sung Ho Jung Suk Jung Choo Cheol Hyun Chung Jae Won Lee Source Type: research

Pages: 1  2  3